We are live on ! Find out more
GBIO

Generation Bio

Delisted

GBIO was delisted on the 6th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$58.6M +$1.1M +16,792 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$56.2M +$79.6K +1,217 +0.1%
AVLSA
3
Atlas Venture Life Science Advisors
Massachusetts
$54.3M – – –
BG
4
Bellevue Group
Switzerland
$23.8M -$359K -5,490 -1%
BlackRock
5
BlackRock
New York
$23M +$2.18M +33,315 +11%
FCM
6
Farallon Capital Management
California
$19M -$3.94M -60,270 -17%
AG
7
Artal Group
Luxembourg
$18.5M – – –
PHS
8
PFM Health Sciences
California
$18.2M +$14.4M +219,903 +383%
YCM
9
Yiheng Capital Management
California
$17M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$14.5M -$8.75M -133,887 -38%
BI
11
BVF Inc
California
$10.3M -$8.15M -124,692 -44%
State Street
12
State Street
Massachusetts
$6M +$366K +5,599 +7%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$5.38M +$180K +2,746 +3%
JP Morgan Chase
14
JP Morgan Chase
New York
$4.23M -$105K -1,602 -2%
HMC
15
Harvard Management Company
Massachusetts
$3.35M – – –
Northern Trust
16
Northern Trust
Illinois
$2.71M +$55K +841 +2%
Charles Schwab
17
Charles Schwab
California
$2.09M +$176K +2,686 +9%
Nuveen
18
Nuveen
North Carolina
$2.05M +$914K +13,985 +81%
Renaissance Technologies
19
Renaissance Technologies
New York
$1.88M +$1.4M +21,463 +296%
HS
20
HighVista Strategies
Massachusetts
$1.63M +$769K +11,769 +90%
Goldman Sachs
21
Goldman Sachs
New York
$1.4M +$55.2K +845 +4%
TD Asset Management
22
TD Asset Management
Ontario, Canada
$1.38M – – –
Morgan Stanley
23
Morgan Stanley
New York
$1.34M -$62.3K -953 -4%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$1.19M -$292K -4,460 -20%
HF
25
HRT Financial
New York
$1.02M +$633K +9,683 +166%